| MolName | (5Z)-5-[[2-(4-benzylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(2-phenylethyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C32H30N4O2S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N3CCC(Cc4ccccc4)CC3)N=C(C=CC=C3)N3C2=O)N(CCc2ccccc2)C1=S |
| InChI | InChI=1S/C32H30N4O2S2/c37-30-26(22-27-31(38)36(32(39)40-27)20-16-23-9-3-1-4-10-23)29(33-28-13-7-8-17-35(28)30)34-18-14-25(15-19-34)21-24-11-5-2-6-12-24/h1-13,17,22,25H,14-16,18-21H2 |
| InChIK | FAOMRJDYDWFNGL-UHFFFAOYSA-N |
| TotalMolweight | 566.748 |
| Molweight | 566.748 |
| MonoisotopicMass | 566.181016 |
| CLogP | 4.2237 |
| CLogS | -6.776 |
| H Acceptors | 6 |
| TotalSurfaceArea | 428.04 |
| Relative PSA | 0.21897 |
| PolarSurfaceArea | 113.61 |
| Druglikeness | 7.042 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.525 |
| Fragments | 1 |
| Non HAtoms | 40 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 7 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 10 |
| Symmetricatoms | 6 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - (5Z)-5-[[2-(4-benzylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(2-phenylethyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[2-(4-benzylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(2-phenylethyl)-2-sulfanylidene-1,3-thiazolidin-4-one